platinum refractory disease
Showing 9976 - 10000 of >10,000
Mild Cognitive Impairment, Hypertension Trial in New York
Recruiting
- Mild Cognitive Impairment
- Hypertension
-
New York, New YorkWeill Cornell Medicine
Mar 14, 2023
Multidimensional Adversity in Inner-City African American
Not yet recruiting
- Diabetic Nephropathy Type 2 - Uncontrolled
- +2 more
- Patient and Community Stakeholder Interviews
- +2 more
-
Milwaukee, WisconsinMedical College of Wisconsin
Jan 11, 2023
Alzheimer, Electric Stimulation Therapy Trial in Beijing (Cortical brain stimulation of mPFC and dlPFC)
Recruiting
- Alzheimer Disease
- Electric Stimulation Therapy
- Cortical brain stimulation of mPFC and dlPFC
-
Beijing, ChinaXuanwu Hospital
Jul 30, 2023
Admission , Treatment and Outcomes of Cardiac Patients in PICU
Not yet recruiting
- Cardiac Disease
- Evidence based management
- (no location specified)
Jun 29, 2022
Pulmonary Vein Stenosis Trial in Boston (Standardized catheterization assessment)
Recruiting
- Pulmonary Vein Stenosis
- Standardized catheterization assessment
-
Boston, MassachusettsBoston Children's Hospital
Jul 8, 2022
Patterns in People With Indolent Non-Hodgkin Lymphoma,Type of
Active, not recruiting
- Relapsed or Refractory Indolent Non-Hodgkin Lymphoma
- Copanlisib (BAY80-6946)
-
Multiple Locations, TaiwanMany Locations
Jan 31, 2023
Clonal Cytopenia of Undetermined Significance, Essential Thrombocythemia, Myelodysplastic Syndrome Trial in Los Angeles
Not yet recruiting
- Clonal Cytopenia of Undetermined Significance
- +4 more
- Biospecimen Collection
- +6 more
-
Los Angeles, California
- +1 more
Oct 4, 2023
A Randomised Controlled Trial
Active, not recruiting
- Diabetes
- Chronic Kidney Diseases
- Minuteful Kidney Test Kit
-
Essex, United Kingdom
- +5 more
Jul 20, 2023
Pancreatic Tumors Trial in Shanghai (Sofantinib?abraxane?gemcitabine, Abraxane combined with gemcitabine)
Not yet recruiting
- Pancreatic Neoplasms
- Sofantinib、abraxane、gemcitabine
- Abraxane combined with gemcitabine
-
Shanghai, ChinaFudan University ShangHai Cancer Center
Jul 31, 2023
Chronic Kidney Diseases, Kidney Failure, Chronic Trial in United States (Decision Aid for Renal Therapy)
Completed
- Chronic Kidney Diseases
- Kidney Failure, Chronic
- Decision Aid for Renal Therapy
-
San Diego, California
- +3 more
Apr 25, 2022
rs243865 and Susceptibility to Cataract Development
Not yet recruiting
- Cataract
- genotyping assay by real-time PCR
- ELISA
-
Sohag, EgyptFaculty of Medicine Sohag University
Dec 31, 2022
Peri-implant Disease and Prosthetic Cement: Cross-sectional
Completed
- Peri-implant Mucositis
- Peri-Implantitis
-
Bologna, ItalyAlma Mater Studiorum - University of Bologna, Department of Biom
Jul 17, 2023
TTP - Thrombotic Thrombocytopenic Purpura Trial in Ankara
Recruiting
- TTP - Thrombotic Thrombocytopenic Purpura
-
Ankara, TurkeyBaskent Universtiy Faculty of Medicine
Jul 15, 2023
POmalidomide Plus LoW Dose Dexa Efficacy in RRMM Patients Under
Completed
- Relapse/Refractory Multiple Myeloma
-
Patra, GreeceAg.Andreas General Hospital
May 10, 2021
Cardiovascular Diseases, Hypertension, Diabetes Trial in New Orleans (Evidence-based interventions recommended by the 2019
Not yet recruiting
- Cardiovascular Diseases
- +3 more
- Evidence-based interventions recommended by the 2019 ACC/AHA Guideline on the Primary Prevention of CVD
-
New Orleans, LouisianaTulane University
Sep 26, 2023
Antifungal in Chronic Pulmonary Aspergillosis
Recruiting
- Chronic Respiratory Disease
- Chronic Pulmonary Aspergillosis
-
Bobigny, FranceHôpital Avicenne
Jun 27, 2022
Peripheral Vascular Disease (PVD), Peripheral Arterial Disease (PAD) Trial in Zhejiang (Spot stent system, Self-expanding
Recruiting
- Peripheral Vascular Disease (PVD)
- Peripheral Arterial Disease (PAD)
- Spot stent system
- Self-expanding peripheral stent system
-
Zhejiang, Zhejiang, ChinaZhejiang Provincial People'S Hospital
Aug 17, 2022
Advanced Melanoma
Enrolling by invitation
- Melanoma
- observational
-
Durham, North CarolinaDuke University Medical Center
Aug 16, 2022
Therapy of Age-related Macular Degeneration
Recruiting
- Age-Related Macular Degeneration
-
Ried Im Innkreis, Upperaustria, AustriaBHS Ried
Aug 16, 2022
Classical Hodgkin Lymphoma Trial in Cologne (Tislelizumab)
Not yet recruiting
- Classical Hodgkin Lymphoma
-
Cologne, Germany1st Department of Medicine, Cologne University Hospital
Aug 5, 2022
COVID-19, Infectious Disease, Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in United States (RQ-001, Placebo)
Recruiting
- COVID-19
- +3 more
- RQ-001
- Placebo
-
Cullman, Alabama
- +8 more
Sep 28, 2023
COVID-19 Pandemic and HRQOL in Cancer Patients and Survivors
Recruiting
- COVID-19 Infection
- Malignant Solid Neoplasm
- Quality-of-Life Assessment
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Sep 22, 2022
Respiratory Distress Syndrome, Newborn Trial in Burlington (PS Group, NCPAP Group, ISX Group)
Completed
- Respiratory Distress Syndrome, Newborn
- PS Group
- +2 more
-
Burlington, VermontVermont Oxford Network
Jan 4, 2023
Acute Lymphoblastic Leukemia Trial in Beijing (CAR-T cells)
Recruiting
- Acute Lymphoblastic Leukemia
- CAR-T cells
-
Beijing, ChinaDepartment of Hematopoietic Stem Cell Transplantation
Feb 6, 2021